标题 |
Open labeled, single arm, multi centered, phase II trial to evaluate the efficacy and safety of combination therapy of rituximab and cladribine for previously untreated patients with advanced staged extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and nodal marginal zone B-cell lymphoma
一项开放标记、单组、多中心、II期试验,旨在评估利妥昔单抗和克拉屈滨联合治疗先前未经治疗的晚期粘膜相关淋巴组织结外边缘区B细胞淋巴瘤(MALT淋巴瘤)和结边缘区B细胞淋巴瘤患者的疗效和安全性
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |